Joan Lunden to Keynote 32nd Annual Miami Breast Cancer Conference

Press Release
Published: Friday, Dec 05, 2014

Plainsboro, NJ – Dec. 3, 2014 – Joan Lunden, award-winning American journalist, bestselling author, and television host, will be the keynote speaker at the 32nd Annual Miami Breast Cancer Conference®. The CME-certified conference will take place February 26 through March 1, 2015, at the Fontainebleau Miami Beach Hotel in Miami Beach, FL.

Lunden, a national health and wellness advocate, publicly announced her battle with triple-negative breast cancer in September and has been documenting her treatment on her video blog on JoanLunden.com. At this year’s conference Lunden will share the emotional side of her journey and her highly personal perspective on optimal patient care.

As host of Good Morning America for nearly 2 decades, Lunden brought insight to top issues for millions of Americans each day. The longest running host ever on early morning television, Lunden reported from 26 countries, covered 4 presidents and 5 Olympics, and kept Americans up-to-date on how to care for their health, their families, and their homes.

Lunden's address on Saturday, February 28, is part of a 4-day CME-certified conference on breast cancer that will attract 1,000 of the world’s top minds in medical, surgical, and radiation oncology. The conference is sponsored by PER®, the go-to source for excellence in continuing medical education.

"The Miami Breast Cancer Conference® has brought together the leading national and international breast cancer physicians for over 31 years, covering all aspects of patient care," said Phil Talamo, Vice President of Independent Medical Education and Operations at PER®. "Our overall goal is to drive the best care for breast cancer patients, and we are delighted to have Joan Lunden share her story and perspective, as it will truly enrich the personal aspect of our mission to help patients."

The conference brings together leading oncologists in multiple disciplines with the aim of fostering awareness of state-of-the-art treatments in each therapeutic area and encouraging cross-team clinical cooperation. Attendees will benefit from opportunities to interact with pioneers of innovative approaches in each of these subspecialties, and to gain insight into the optimal multidisciplinary management of patients with breast cancer.

This CME-certified activity is directed at medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

PER® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Incorporating instructional design with principles of adult learning, PER® sponsors multi-day congresses, 1-day update conferences, regional meetings, online case discussions, and faculty dialogues. These educational activities enable health care professionals to remain current with and responsive to advances in medical care for patients with cancer—from diagnosis through treatment—with the ultimate goal of improving patient outcomes.

To register or view the conference agenda, please visit www.gotoper.com

###

About Physicians’ Education Resource®, LLC

PER® is the go-to resource, specializing in live and online CME-certified activities focusing on oncology and hematology. Based on identified needs and practice gaps, PER® provides high-quality, evidence-based activities featuring leading national and international faculty, with a focus on practice-changing advances and standards of care in treatment and disease management. PER® serves the oncology health care community, including physicians, fellows, physician assistants, advanced practice nurses, nurses, pharmacists, and researchers. Learn more at www.gotoper.com.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x